The DOI matches its Crossref record; 134 of the 134 references it cites were found in a registry or an index.
Hepatocellular carcinoma: current trends in worldwide epidemiology, risk factors, diagnosis, and therapeutics
Open accessAbstract
Hepatocellular carcinoma (HCC) is a common malignancy in developing countries and its incidence is on the rise in the developing world. The epidemiology of this cancer is unique since its risk factors, including hepatitis C and B, have been clearly established. The current trends in the shifting incidence of HCC in different regions of the world can be explained partly by the changing prevalence of hepatitis. Early detection offers the only hope for curative treatment for patients with HCC, hence effective screening strategies for high-risk patients is of utmost importance. Liver transplantation and surgical resection remains the cornerstone of curative treatment. But major advances in locoregional therapies and molecular-targeted therapies for the treatment of advanced HCC have occurred recently. In this review, current trends in the worldwide epidemiology, surveillance, diagnosis, standard treatments, and the emerging therapies for HCC are discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Bray, F., Center, M. M., Ferlay, J., Ward, E., & Forman, D. (2011) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.20107 · Cited by 54,679
Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008
Ferlay, J., Shin, H., Bray, F., Forman, D., Mathers, C., & Parkin, D. M. (2010) · International Journal of Cancer · doi:10.1002/ijc.25516 · Cited by 21,293
Sorafenib in advanced hepatocellular carcinoma
Llovet, J. M., Ricci, S., Mazzaferro, V., Hilgard, P., Gane, E., Blanc, J.-F., de Oliveira, A. C., Santoro, A., Raoul, J.-L., Forner, A., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0708857 · Cited by 13,097
SEER Cancer Statistics Review, 1975-2003
Ries, L. A. G., Harkins, D., Krapcho, M. F., Mariotto, A. B., Miller, B., Feuer, E. J., Clegg, L. X., Eisner, M. P., Horner, M., Howlader, N., et al. (2006) · Digital Archive @ GSU · Cited by 11,775
Management of Hepatocellular Carcinoma: An Update Δσ
Bruix, J., & Sherman, M. (2011) · Hepatology · doi:10.1002/hep.24199 · Cited by 8,103
Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. Adults
Calle, E. E., Rodriguez, C., Walker-Thurmond, K., & Thun, M. J. (2003) · New England Journal of Medicine · doi:10.1056/nejmoa021423 · Cited by 7,696
Mazzaferro, V., Regalia, E., Doci, R., Andreola, S., Pulvirenti, A., Bozzetti, F., Montalto, F., Ammatuna, M., Morabito, A., & Gennari, L. (1996) · New England Journal of Medicine · doi:10.1056/nejm199603143341104 · Cited by 7,186
Management of Hepatocellular Carcinoma *
Bruix, J., & Sherman, M. (2005) · Hepatology · doi:10.1002/hep.20933 · Cited by 5,857
Cheng, A.-L., Kang, Y.-K., Chen, Z., Tsao, C.-J., Qin, S., Kim, J. S., Luo, R., Feng, J., Ye, S., Yang, T.-S., et al. (2009) · The Lancet Oncology · doi:10.1016/s1470-2045(08)70285-7 · Cited by 5,832
Sorafenib in Advanced Hepatocellular Carcinoma
정, 재. (2008) · Cited by 5,586
Clinical Management of Hepatocellular Carcinoma. Conclusions of the Barcelona-2000 EASL Conference
Bruix, J., Sherman, M., Llovet, J. M., Beaugrand, M., Lencioni, R., Burroughs, A. K., Christensen, E., Pagliaro, L., Colombo, M., & Rodés, J. (2001) · Journal of Hepatology · doi:10.1016/s0168-8278(01)00130-1 · Cited by 4,089
Prognosis of Hepatocellular Carcinoma: The BCLC Staging Classification
Llovet, J., Brú, C., & Bruix, J. (1999) · Seminars in Liver Disease · doi:10.1055/s-2007-1007122 · Cited by 3,805
Llovet, J. M., Real, M. I., Montaña, X., Planas, R., Coll, S., Aponte, J., Ayuso, C., Sala, M., Muchart, J., Solà, R., et al. (2002) · The Lancet · doi:10.1016/s0140-6736(02)08649-x · Cited by 3,494
Llovet, J. M., & Bruix, J. (2003) · Hepatology · doi:10.1053/jhep.2003.50047 · Cited by 3,029
The global health burden of infection‐associated cancers in the year 2002
Parkin, D. M. (2006) · International Journal of Cancer · doi:10.1002/ijc.21731 · Cited by 2,932
Rising Incidence of Hepatocellular Carcinoma in the United States
El-Serag, H. B., & Mason, A. C. (1999) · New England Journal of Medicine · doi:10.1056/nejm199903113401001 · Cited by 2,853
Lo, C.-M., Ngan, H., Tso, W.-K., Liu, C.-L., Lam, C.-M., Poon, R. T.-P., Fan, S.-T., & Wong, J. (2002) · Hepatology · doi:10.1053/jhep.2002.33156 · Cited by 2,613
Lamivudine for Patients with Chronic Hepatitis B and Advanced Liver Disease
Liaw, Y.-F., Sung, J. J. Y., Chow, W. C., Farrell, G., Lee, C.-Z., Yuen, H., Tanwandee, T., Tao, Q.-M., Shue, K., Keene, O. N., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa033364 · Cited by 2,266
Nonalcoholic Steatohepatitis: Summary of An Aasld Single Topic Conference
Neuschwander-Tetri, B. A., & Caldwell, S. H. (2003) · Hepatology · doi:10.1053/jhep.2003.50193 · Cited by 2,154
Llovet, J. M., Fuster, J., & Bruix, J. (1999) · Hepatology · doi:10.1002/hep.510300629 · Cited by 1,708
Altekruse, S. F., McGlynn, K. A., & Reichman, M. E. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.20.7753 · Cited by 1,694
Lammer, J., Malagari, K., Vogl, T., Pilleul, F., Denys, A., Watkinson, A., Pitton, M., Sergent, G., Pfammatter, T., Terraz, S., et al. (2010) · CardioVascular and Interventional Radiology · doi:10.1007/s00270-009-9711-7 · Cited by 1,557
Randomized controlled trial of screening for hepatocellular carcinoma
Zhang, B.-H., Yang, B.-H., & Tang, Z.-Y. (2004) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/s00432-004-0552-0 · Cited by 1,496
Bugianesi, E., Leone, N., Vanni, E., Marchesini, G., Brunello, F., Carucci, P., Musso, A., De Paolis, P., Capussotti, L., Salizzoni, M., et al. (2002) · Gastroenterology · doi:10.1053/gast.2002.34168 · Cited by 1,439
Ascha, M. S., Hanouneh, I. A., Lopez, R., Tamimi, T. A.-R., Feldstein, A. F., & Zein, N. N. (2010) · Hepatology · doi:10.1002/hep.23527 · Cited by 1,296
Tissue Ablation with Irreversible Electroporation
Davalos, R. V., Mir, L. M., & Rubinsky, B. (2005) · Annals of Biomedical Engineering · doi:10.1007/s10439-005-8981-8 · Cited by 1,293
Risk Factors for Hepatocellular Carcinoma among Patients with Chronic Liver Disease
Tsukuma, H., Hiyama, T., Tanaka, S., Nakao, M., Yabuuchi, T., Kitamura, T., Nakanishi, K., Fujimoto, I., Inoue, A., Yamazaki, H., et al. (1993) · New England Journal of Medicine · doi:10.1056/nejm199306243282501 · Cited by 1,126
Salem, R., Lewandowski, R. J., Mulcahy, M. F., Riaz, A., Ryu, R. K., Ibrahim, S., Atassi, B., Baker, T., Gates, V., Miller, F. H., et al. (2010) · Gastroenterology · doi:10.1053/j.gastro.2009.09.006 · Cited by 1,074
Forner, A., Vilana, R., Ayuso, C., Bianchi, L., Solé, M., Ayuso, J. R., Boix, L., Sala, M., Varela, M., Llovet, J. M., et al. (2008) · Hepatology · doi:10.1002/hep.21966 · Cited by 1,032
Lencioni, R. A., Allgaier, H.-P., Cioni, D., Olschewski, M., Deibert, P., Crocetti, L., Frings, H., Laubenberger, J., Zuber, I., Blum, H. E., et al. (2003) · Radiology · doi:10.1148/radiol.2281020718 · Cited by 998
The Continuing Increase in the Incidence of Hepatocellular Carcinoma in the United States: An Update
El-Serag, H. B., Davila, J. A., Petersen, N. J., & McGlynn, K. A. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-10-200311180-00009 · Cited by 943
Varela, M., Real, M. I., Burrel, M., Forner, A., Sala, M., Brunet, M., Ayuso, C., Castells, L., Montañá, X., Llovet, J. M., et al. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2006.10.020 · Cited by 941
Davis, G. L., Alter, M. J., El–Serag, H., Poynard, T., & Jennings, L. W. (2010) · Gastroenterology · doi:10.1053/j.gastro.2009.09.067 · Cited by 878
El–Serag, H. B., Hampel, H., & Javadi, F. (2006) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2005.12.007 · Cited by 826
Tung-Ping Poon, R., Fan, S.-T., & Wong, J. (2000) · Annals of Surgery · doi:10.1097/00000658-200007000-00003 · Cited by 811
Hassan, M. M., Hwang, L.-Y., Hatten, C. J., Swaim, M., Li, D., Abbruzzese, J. L., Beasley, P., & Patt, Y. Z. (2002) · Hepatology · doi:10.1053/jhep.2002.36780 · Cited by 762
Ishizawa, T., Hasegawa, K., Aoki, T., Takahashi, M., Inoue, Y., Sano, K., Imamura, H., Sugawara, Y., Kokudo, N., & Makuuchi, M. (2008) · Gastroenterology · doi:10.1053/j.gastro.2008.02.091 · Cited by 754
Aflatoxin: a 50-year odyssey of mechanistic and translational toxicology
Kensler, T. W., Roebuck, B. D., Wogan, G. N., & Groopman, J. D. (2011) · Toxicological Sciences · doi:10.1093/toxsci/kfq283 · Cited by 703
Donato, F. (2002) · American Journal of Epidemiology · doi:10.1093/aje/155.4.323 · Cited by 677
Sangro, B., Carpanese, L., Cianni, R., Golfieri, R., Gasparini, D., Ezziddin, S., Paprottka, P. M., Fiore, F., Van Buskirk, M., Bilbao, J. I., et al. (2011) · Hepatology · doi:10.1002/hep.24451 · Cited by 652
Lok, A. S., Seeff, L. B., Morgan, T. R., di Bisceglie, A. M., Sterling, R. K., Curto, T. M., Everson, G. T., Lindsay, K. L., Lee, W. M., Bonkovsky, H. L., et al. (2009) · Gastroenterology · doi:10.1053/j.gastro.2008.09.014 · Cited by 651
Salem, R., Lewandowski, R. J., Kulik, L., Wang, E., Riaz, A., Ryu, R. K., Sato, K. T., Gupta, R., Nikolaidis, P., Miller, F. H., et al. (2011) · Gastroenterology · doi:10.1053/j.gastro.2010.10.049 · Cited by 650
Bolondi, L., Sofia, S., Siringo, S., Gaiani, S., Casali, A., Zironi, G., Piscaglia, F., Gramantieri, L., Zanetti, M., & Sherman, M. (2001) · Gut · doi:10.1136/gut.48.2.251 · Cited by 643
Prognosis of hepatocellular carcinoma: Comparison of 7 staging systems in an American cohort†
Marrero, J. A., Fontana, R. J., Barrat, A., Askari, F., Conjeevaram, H. S., Su, G. L., & Lok, A. S. (2005) · Hepatology · doi:10.1002/hep.20636 · Cited by 637
Decreased Incidence of Hepatocellular Carcinoma in Hepatitis B Vaccinees: A 20-Year Follow-up Study
Chang, M.-H., You, S.-L., Chen, C.-J., Liu, C.-J., Lee, C.-M., Lin, S.-M., Chu, H.-C., Wu, T.-C., Yang, S.-S., Kuo, H.-S., et al. (2009) · JNCI: Journal of the National Cancer Institute · doi:10.1093/jnci/djp288 · Cited by 635
Bruno, S., Stroffolini, T., Colombo, M., Bollani, S., Benvegnù, L., Mazzella, G., Ascione, A., Santantonio, T., Piccinino, F., Andreone, P., et al. (2007) · Hepatology · doi:10.1002/hep.21492 · Cited by 604
Associations Between Hepatitis B Virus Genotype and Mutants and the Risk of Hepatocellular Carcinoma
Yang, H.-I., Yeh, S.-H., Chen, P.-J., Iloeje, U. H., Jen, C.-L., Su, J., Wang, L.-Y., Lu, S.-N., You, S.-L., Chen, D.-S., et al. (2008) · JNCI Journal of the National Cancer Institute · doi:10.1093/jnci/djn243 · Cited by 580
Benign and malignant nodules in cirrhotic livers: distinction based on blood supply.
Matsui, O., Kadoya, M., Kameyama, T., Yoshikawa, J., Takashima, T., Nakanuma, Y., Unoura, M., Kobayashi, K., Izumi, R., & Ida, M. (1991) · Radiology · doi:10.1148/radiology.178.2.1846240 · Cited by 562
Lok, A. S., Sterling, R. K., Everhart, J. E., Wright, E. C., Hoefs, J. C., Di Bisceglie, A. M., Morgan, T. R., Kim, H., Lee, W. M., Bonkovsky, H. L., et al. (2010) · Gastroenterology · doi:10.1053/j.gastro.2009.10.031 · Cited by 558
Donato, F., Boffetta, P., & Puoti, M. (1998) · International Journal of Cancer · doi:10.1002/(sici)1097-0215(19980130)75:3<347::aid-ijc4>3.0.co;2-2 · Cited by 543
Colli, A., Fraquelli, M., Casazza, G., Massironi, S., Colucci, A., Conte, D., & Duca, P. (2006) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2006.00467.x · Cited by 540
Silva, M. A., Hegab, B., Hyde, C., Guo, B., Buckels, J. A. C., & Mirza, D. F. (2008) · Gut · doi:10.1136/gut.2008.149062 · Cited by 536
Local-Regional Treatment of Hepatocellular Carcinoma
Lencioni, R., & Crocetti, L. (2012) · Radiology · doi:10.1148/radiol.11110144 · Cited by 514
Loco‐regional treatment of hepatocellular carcinoma†
Lencioni, R. (2010) · Hepatology · doi:10.1002/hep.23725 · Cited by 509
Prolonged Therapy of Advanced Chronic Hepatitis C with Low-Dose Peginterferon
Di Bisceglie, A. M., Shiffman, M. L., Everson, G. T., Lindsay, K. L., Everhart, J. E., Wright, E. C., Lee, W. M., Lok, A. S., Bonkovsky, H. L., Morgan, T. R., et al. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707615 · Cited by 465
Phase II Study of Erlotinib (OSI-774) in Patients With Advanced Hepatocellular Cancer
Philip, P. A., Mahoney, M. R., Allmer, C., Thomas, J., Pitot, H. C., Kim, G., Donehower, R. C., Fitch, T., Picus, J., & Erlichman, C. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.14.696 · Cited by 462
Burrel, M., Llovet, J. M., Ayuso, C., Iglesias, C., Sala, M., Miquel, R., Caralt, T., Ayuso, J. R., Solé, M., Sanchez, M., et al. (2003) · Hepatology · doi:10.1002/hep.1840380430 · Cited by 451
Abou-Alfa, G. K., Johnson, P., Knox, J. J., Capanu, M., Davidenko, I., Lacava, J., Leung, T., Gansukh, B., & Saltz, L. B. (2010) · JAMA · doi:10.1001/jama.2010.1672 · Cited by 448
Graziadei, I. W., Sandmueller, H., Waldenberger, P., Koenigsrainer, A., Nachbaur, K., Jaschke, W., Margreiter, R., & Vogel, W. (2003) · Liver Transplantation · doi:10.1053/jlts.2003.50106 · Cited by 439
Results of the first year of the new liver allocation plan
Freeman, R. B., Wiesner, R. H., Edwards, E., Harper, A., Merion, R., & Wolfe, R. (2004) · Liver Transplantation · doi:10.1002/lt.20024 · Cited by 434
17. Management of Hepatocellular Carcinoma: an Update
Kudo, M. (2018) · Nihon Naika Gakkai Zasshi · doi:10.2169/naika.107.133b · Cited by 425
Gupta, S., Bent, S., & Kohlwes, J. (2003) · Annals of Internal Medicine · doi:10.7326/0003-4819-139-1-200307010-00012 · Cited by 420
Risk Factors for the Rising Rates of Primary Liver Cancer in the United States
El-Serag, H. B., & Mason, A. C. (2000) · Archives of Internal Medicine · doi:10.1001/archinte.160.21.3227 · Cited by 418
Sangiovanni, A., Manini, M. A., Iavarone, M., Romeo, R., Forzenigo, L. V., Fraquelli, M., Massironi, S., Della Corte, C., Ronchi, G., Rumi, M. G., et al. (2010) · Gut · doi:10.1136/gut.2009.187286 · Cited by 408
Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults*
(2003) · Obstetrics & Gynecology · doi:10.1097/00006250-200308000-00039 · Cited by 401
Use of Surveillance for Hepatocellular Carcinoma Among Patients With Cirrhosis in the United States
Davila, J. A., Morgan, R. O., Richardson, P. A., Du, X. L., McGlynn, K. A., & El-Serag, H. B. (2010) · Hepatology · doi:10.1002/hep.23615 · Cited by 392
11C-acetate PET imaging in hepatocellular carcinoma and other liver masses.
Ho, C.-L., Yu, S. C. H., & Yeung, D. W. C. (2003) · PubMed · Cited by 375
Hepatitis B virus DNA levels and outcomes in chronic hepatitis B # †
Chen, C.-J., Yang, H.-I., & Iloeje, U. H. (2009) · Hepatology · doi:10.1002/hep.22884 · Cited by 346
Thomas, M. B., Morris, J. S., Chadha, R., Iwasaki, M., Kaur, H., Lin, E., Kaseb, A., Glover, K., Davila, M., & Abbruzzese, J. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.18.3301 · Cited by 334
Kulik, L. M., Atassi, B., van Holsbeeck, L., Souman, T., Lewandowski, R. J., Mulcahy, M. F., Hunter, R. D., Nemcek, A. A., Abecassis, M. M., Haines, K. G., et al. (2006) · Journal of Surgical Oncology · doi:10.1002/jso.20609 · Cited by 333
Chen, J., Yang, H., Iloeje, U. H., You, S., Lu, S., Wang, L., Su, J., Sun, C., Liaw, Y., & Chen, C. (2010) · Gastroenterology · doi:10.1053/j.gastro.2010.01.042 · Cited by 331
Trevisani, F. (2002) · The American Journal of Gastroenterology · doi:10.1016/s0002-9270(01)04119-3 · Cited by 313
Kim, S. H., Kim, S. H., Lee, J., Kim, M. J., Jeon, Y. H., Park, Y., Choi, D., Lee, W. J., & Lim, H. K. (2009) · American Journal of Roentgenology · doi:10.2214/ajr.08.1262 · Cited by 311
Hepatocellular carcinoma in patients with nonalcoholic steatohepatitis
Hashimoto, E., Yatsuji, S., Tobari, M., Taniai, M., Torii, N., Tokushige, K., & Shiratori, K. (2009) · Journal of Gastroenterology · doi:10.1007/s00535-008-2262-x · Cited by 308
Hepatocellular carcinoma: Recent trends in Japan
Kiyosawa, K., Umemura, T., Ichijo, T., Matsumoto, A., Yoshizawa, K., Gad, A., & Tanaka, E. (2004) · Gastroenterology · doi:10.1053/j.gastro.2004.09.012 · Cited by 308
Hepatitis B‐related hepatocellular carcinoma: epidemiological characteristics and disease burden
Nguyen, V. T. T., Law, M. G., & Dore, G. J. (2009) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2009.01117.x · Cited by 302
Sala, M., Fuster, J., Llovet, J. M., Navasa, M., Solé, M., Varela, M., Pons, F., Rimola, A., García-Valdecasas, J. C., Brú, C., et al. (2004) · Liver Transplantation · doi:10.1002/lt.20202 · Cited by 297
Poon, R. T. P., Tso, W. K., Pang, R. W. C., Ng, K. K. C., Woo, R., Tai, K. S., & Fan, S. T. (2007) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2007.04.021 · Cited by 294
Hepatocellular carcinoma and hepatitis C in the United States
El-Serag, H. B. (2002) · Hepatology · doi:10.1002/hep.1840360710 · Cited by 291
Li, X. (2004) · World Journal of Gastroenterology · doi:10.3748/wjg.v10.i19.2878 · Cited by 290
A prospective study on downstaging of hepatocellular carcinoma prior to liver transplantation
Yao, F. Y., Hirose, R., LaBerge, J. M., Davern, T. J., Bass, N. M., Kerlan, R. K., Merriman, R., Feng, S., Freise, C. E., Ascher, N. L., et al. (2005) · Liver Transplantation · doi:10.1002/lt.20526 · Cited by 288
Park, J.-W., Kim, J. H., Kim, S. K., Kang, K. W., Park, K. W., Choi, J.-I., Lee, W. J., Kim, C.-M., & Nam, B. H. (2008) · Journal of Nuclear Medicine · doi:10.2967/jnumed.108.055087 · Cited by 287
A phase II study of lapatinib in patients with advanced biliary tree and hepatocellular cancer
Ramanathan, R. K., Belani, C. P., Singh, D. A., Tanaka, M., Lenz, H.-J., Yen, Y., Kindler, H. L., Iqbal, S., Longmate, J., Mack, P. C., et al. (2009) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-009-0927-7 · Cited by 284
Nomograms for Risk of Hepatocellular Carcinoma in Patients With Chronic Hepatitis B Virus Infection
Yang, H.-I., Sherman, M., Su, J., Chen, P.-J., Liaw, Y.-F., Iloeje, U. H., & Chen, C.-J. (2010) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.4456 · Cited by 281
Vilana, R., Bruix, J., Bru, C., Ayuso, C., Solé, M., & Rodés, J. (1992) · Hepatology · doi:10.1002/hep.1840160212 · Cited by 270
Okazumi, S., Isono, K., Enomoto, K., Kikuchi, T., Ozaki, M., Yamamoto, H., Hayashi, H., Asano, T., & Ryu, M. (1992) · PubMed · Cited by 257
Phase 2 study of cetuximab in patients with advanced hepatocellular carcinoma
Zhu, A. X., Stuart, K., Blaszkowsky, L. S., Muzikansky, A., Reitberg, D. P., Clark, J. W., Enzinger, P. C., Bhargava, P., Meyerhardt, J. A., Horgan, K., et al. (2007) · Cancer · doi:10.1002/cncr.22829 · Cited by 246
Grieco, A., Pompili, M., Caminiti, G., Miele, L., Covino, M., Alfei, B., Rapaccini, G. L., & Gasbarrini, G. (2005) · Gut · doi:10.1136/gut.2004.048124 · Cited by 242
Microwave Ablation of Hepatocellular Carcinoma
Liang, P., & Wang, Y. (2007) · Oncology · doi:10.1159/000111718 · Cited by 234
Natural history of hepatitis-related hepatocellular carcinoma
But, D.-Y.-K. (2008) · World Journal of Gastroenterology · doi:10.3748/wjg.14.1652 · Cited by 232
Marrero, J. A., Hussain, H. K., Nghiem, H. V., Umar, R., Fontana, R. J., & Lok, A. S. (2005) · Liver Transplantation · doi:10.1002/lt.20357 · Cited by 231
Epidemiology of hepatitis C in the United States
Williams, I. (1999) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)00373-3 · Cited by 230
Singal, A. K., Singh, A., Jaganmohan, S., Guturu, P., Mummadi, R., Kuo, Y., & Sood, G. K. (2010) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2009.10.026 · Cited by 229
Yoshizawa, H. (2002) · Oncology · doi:10.1159/000048270 · Cited by 229
Georgiades, C. S., Hong, K., D'Angelo, M., & Geschwind, J.-F. H. (2005) · Journal of Vascular and Interventional Radiology · doi:10.1097/01.rvi.0000182185.47500.7a · Cited by 226
Coffee consumption and risk of liver cancer: A meta-analysis
Larsson, S. C., & Wolk, A. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.03.044 · Cited by 218
Finn, R. S., Kang, Y.-K., Mulcahy, M., Polite, B. N., Lim, H. Y., Walters, I., Baudelet, C., Manekas, D., & Park, J.-W. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-1991 · Cited by 215
Maddala, Y. K., Stadheim, L., Andrews, J. C., Burgart, L. J., Rosen, C. B., Kremers, W. K., & Gores, G. (2004) · Liver Transplantation · doi:10.1002/lt.20099 · Cited by 214
Lok, A. S., Everhart, J. E., Wright, E. C., Di Bisceglie, A. M., Kim, H., Sterling, R. K., Everson, G. T., Lindsay, K. L., Lee, W. M., Bonkovsky, H. L., et al. (2011) · Gastroenterology · doi:10.1053/j.gastro.2010.11.050 · Cited by 192
Strobel, D., Seitz, K., Blank, W., Schuler, A., Dietrich, C., von Herbay, A., Friedrich-Rust, M., & Bernatik, T. (2009) · Ultraschall in der Medizin - European Journal of Ultrasound · doi:10.1055/s-0028-1109672 · Cited by 177
Stickel, F., & Hellerbrand, C. (2010) · Gut · doi:10.1136/gut.2009.199661 · Cited by 174
Bouza, C., López‐Cuadrado, T., Alcázar, R. A., Saz‐Parkinson, Z., & Amate, J. M. (2009) · BMC Gastroenterology · doi:10.1186/1471-230x-9-31 · Cited by 159
Liu, C., Lee, P., Lin, D., Wu, C.-C., Jeng, L., Lin, P.-W., Mok, K., Lee, W., Yeh, H., Ho, M., et al. (2009) · Journal of Hepatology · doi:10.1016/j.jhep.2008.12.023 · Cited by 155
Cancer incidence in people with hepatitis B or C infection: A large community-based linkage study
Amin, J., Dore, G. J., O’Connell, D. L., Bartlett, M., Tracey, E. A., Kaldor, J. M., & Law, M. G. (2006) · Journal of Hepatology · doi:10.1016/j.jhep.2006.02.014 · Cited by 153
Park, J., Finn, R. S., Kim, J. S., Karwal, M., Li, R. K., Ismail, F., Thomas, M. B., Harris, R., Baudelet, C., Walters, I. B., et al. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-10-2011 · Cited by 148
Gaudio, M. D., Ercolani, G., Ravaioli, M., Cescon, M., Lauro, A., Vivarelli, M., Zanello, M., Cucchetti, A., Vetrone, G., Tuci, F., et al. (2008) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2008.02229.x · Cited by 147
Bridging Locoregional Therapy for Hepatocellular Carcinoma Prior to Liver Transplantation
Heckman, J. T., DeVera, M., Marsh, J. W., Fontes, P., Amesur, N. B., Holloway, S. E., Nalesnik, M. A., Geller, D. A., Steel, J. L., & Gamblin, T. C. (2008) · Annals of Surgical Oncology · doi:10.1245/s10434-008-0071-3 · Cited by 136
Asnacios, A., Fartoux, L., Romano, O., Tesmoingt, C., Louafi, S., Mansoubakht, T., Artru, P., Poynard, T., Rosmorduc, O., Hebbar, M., et al. (2008) · Cancer · doi:10.1002/cncr.23489 · Cited by 135
Prevention of recurrence after resection of hepatocellular carcinoma: A daunting challenge
Poon, R. T. P. (2011) · Hepatology · doi:10.1002/hep.24569 · Cited by 130
Effect of vitamin K2 on the recurrence of hepatocellular carcinoma
Yoshida, H., Shiratori, Y., Kudo, M., Shiina, S., Mizuta, T., Kojiro, M., Yamamoto, K., Koike, Y., Saito, K., Koyanagi, N., et al. (2011) · Hepatology · doi:10.1002/hep.24430 · Cited by 127 · cited 2×
“Several approaches have failed when taken into larger trials, such as the use of retinoid and vitamin K2.”
MethodChanging disease burden of hepatocellular carcinoma in the Far East and Southeast Asia
Kao, J., & Chen, D. (2005) · Liver International · doi:10.1111/j.1478-3231.2005.01139.x · Cited by 124
Ariff, B., Lloyd, C., Khan, S., Shariff, M. I. F., Thillainayagam, A. V., Bansi, D. S., Khan, S. A., Taylor-Robinson, S. D., & Lim, A. K. P. (2009) · World Journal of Gastroenterology · doi:10.3748/wjg.15.1289 · Cited by 118
Bekaii‐Saab, T., Markowitz, J., Prescott, N. L., Sadée, W., Heerema, N. A., Wei, L., Zunyan Dai, Y., Papp, A. C., Campbell, A., Culler, K., et al. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-09-0465 · Cited by 112
Hepatitis B virus in hepatocarcinogenesis
Feitelson, M. A. (1999) · Journal of Cellular Physiology · Cited by 107
O'Dwyer, P. J., Giantonio, B. J., Levy, D. E., Kauh, J. S. W., Fitzgerald, D. B., & Benson, A. B. (2006) · Journal of Clinical Oncology · doi:10.1200/jco.2006.24.18_suppl.4143 · Cited by 106
The combination of sorafenib with transarterial chemoembolisation for hepatocellular carcinoma
Cabrera, R., Pannu, D. S., Caridi, J. G., Firpi, R. J., Soldevila‐Pico, C., Morelli, G., Clark, V., Suman, A., George, T. J., & Nelson, D. R. (2011) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2011.04697.x · Cited by 96
Self-citationResection of hepatocellular carcinoma in patients with cirrhosis
Balsells, J., Charco, R., Lázaro, J. L., Murio, E., Vargas, V., Allende, E., & Margarit, C. (1996) · British journal of surgery · doi:10.1002/bjs.1800830610 · Cited by 91
Dufour, J., Hoppe, H., Heim, M. H., Helbling, B., Maurhofer, O., Szucs‐Farkas, Z., Kickuth, R., Borner, M., Candinas, D., & Saar, B. (2010) · The Oncologist · doi:10.1634/theoncologist.2010-0180 · Cited by 90
Rising incidence of hepatocellular carcinoma in the United States
Hashem, B. J., & Andrew, C. D. (1999) · European Journal of Gastroenterology & Hepatology · doi:10.1097/00042737-199905000-00020 · Cited by 88
Breitenstein, S., Apestegui, C., Petrowsky, H., & Clavien, P. (2009) · World Journal of Surgery · doi:10.1007/s00268-008-9878-0 · Cited by 83
Hepatocellular carcinoma with nonalcoholic steatohepatitis
Mori, S., Yamasaki, T., Sakaida, I., Takami, T., Sakaguchi, E., Kimura, T., Kurokawa, F., Maeyama, S., & Okita, K. (2004) · Journal of Gastroenterology · doi:10.1007/s00535-003-1308-3 · Cited by 75
A Critical Appraisal of the Literature on Local Ablative Therapies for Hepatocellular Carcinoma
Lencioni, R. A., & Crocetti, L. (2005) · Clinics in Liver Disease · doi:10.1016/j.cld.2004.12.002 · Cited by 63
Marrero, J. A., & El‐Serag, H. B. (2010) · Hepatology · doi:10.1002/hep.24033 · Cited by 62
Clinical management of focal liver lesions: the key role of real-time contrast-enhanced US
Lencioni, R. A., Pina, C. D., Crocetti, L., Bozzi, E., & Cioni, D. (2007) · European Radiology Supplements · doi:10.1007/s10406-007-0231-8 · Cited by 49
Serological Surveillance for hepatocellular carcinoma: Time to quit
Sherman, M. (2010) · Journal of Hepatology · doi:10.1016/j.jhep.2009.11.026 · Cited by 45
Gadoxetate acid-enhanced MR imaging for HCC: A review for clinicians
Chanyaputhipong, J., Low, S.-C. A., & Chow, P. K. H. (2011) · International Journal of Hepatology · doi:10.4061/2011/489342 · Cited by 41
Hepatocellular Carcinoma Arising from Nonalcoholic Steatohepatitis: Report of Two Cases
Hai, S., Kubo, S., Shuto, T., Tanaka, H., Takemura, S., Yamamoto, T., Kanazawa, A., Ogawa, M., Hirohashi, K., & Wakasa, K. (2006) · Surgery Today · doi:10.1007/s00595-005-3167-4 · Cited by 40
Does Antiviral Therapy Prevent Hepatocellular Carcinoma?
Kwon, H. K., & Lok, A. S.-F. (2011) · Antiviral Therapy · doi:10.3851/imp1895 · Cited by 35
Jasinghe, V. J., Xie, Z., Zhou, J., Khng, J., Poon, L.-F., Palaniyandi, S., Glaser, K. B., Albert, D. H., Davidsen, S. K., & Chen, C.-S. (2008) · Journal of Hepatology · doi:10.1016/j.jhep.2008.08.010 · Cited by 34
A phase II study of AZD6244 in advanced or metastatic hepatocellular carcinoma
O’Neil, B. H., Williams-Goff, L. W., Kauh, J. S. W., Bekaii‐Saab, T., Strosberg, J., Lee, R. J., Deal, A., Sullivan, D. M., & Sebti, S. M. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2009.27.15_suppl.e15574 · Cited by 30
Imaging of the Liver for Hepatocellular Cancer
Outwater, E. K. (2010) · Cancer Control · doi:10.1177/107327481001700202 · Cited by 28
Sun, W., Nelson, D., Alberts, S. R., Poordad, F. F., Leong, S., Teitelbaum, U. R., Woods, L., Fox, N. L., & O’Neil, B. H. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.29.4_suppl.261 · Cited by 20
Alpha-Fetoprotein in Early Hepatocellular Carcinoma
Marrero, J. A., & Feng, Z. (2009) · Gastroenterology · doi:10.1053/j.gastro.2009.08.076 · Cited by 12
Cited by
Global patterns of hepatocellular carcinoma management from diagnosis to death: the BRIDGE Study
Park, J., Chen, M., Colombo, M., Roberts, L. R., Schwartz, M., Chen, P., Kudo, M., Johnson, P., Wagner, S., Orsini, L. S., et al. (2015) · Liver International · doi:10.1111/liv.12818 · Cited by 1,245
Non-coding RNAs in hepatocellular carcinoma: molecular functions and pathological implications
Wong, C.-M., Tsang, F. H.-C., & Ng, I. O.-L. (2018) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/nrgastro.2017.169 · Cited by 424
Wang, F., Ying, H.-Q., He, B.-S., Pan, Y.-Q., Deng, Q.-W., Sun, H.-L., Chen, J., Liu, X., & Wang, S.-K. (2015) · Oncotarget · doi:10.18632/oncotarget.3219 · Cited by 348
Shang, X., Li, G., Liu, H., Li, T., Liu, J., Zhao, Q., & Wang, C. (2016) · Medicine · doi:10.1097/md.0000000000003811 · Cited by 330
Figarola, J. L., Singhal, J., Tompkins, J. D., Rogers, G. W., Warden, C., Horne, D., Riggs, A. D., Awasthi, S., & Singhal, S. S. (2015) · Journal of Biological Chemistry · doi:10.1074/jbc.m115.686352 · Cited by 41
Metadata
- Authors
- Cabrera, R.
- Venue
- Hepatic Medicine: Evidence and Research
- Publisher
- Informa UK Limited
- Published
- 2012-05
- Volume
- 4
- Pages
- 19
- ISSN
- 1179-1535 (ISSN-L)
- OpenAlex
- W2015772717
- Cited by
- 274
- References
- 134
- FWCI
- 7.64
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.